Cochrane · systematic review · CD013358

Meditation for the primary and secondary prevention of cardiovascular disease

Rees, K, Takeda, A, Court, R, et al. · Cochrane Database of Systematic Reviews · 2024 · Cochrane Library

HeartAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
36
current version
GRADE rated
26
No studies
10
Included studies
NR
No studies 10 · 27.8%Ungraded 0 · 0%Very low 2 · 5.6%Low 18 · 50%Moderate 6 · 16.7%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Mindfulness‐based interventions (MBIs) compared to active comparators for the primary and secondary prevention of cardiovascular disease

Population: people at high risk of or withcardiovascular disease
9 questions
OutcomeEffectEvidenceStatus / GRADE
Clinical CVD events
Mindfulness‐based interventions (MBIs) vs active comparators
no estimate extractedNRNo studies
Systolic blood pressure (mmHg), change from baseline
Mindfulness‐based interventions (MBIs) vs active comparators
no estimate extracted6 studies · 388 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Diastolic blood pressure (mmHg), change from baseline
Mindfulness‐based interventions (MBIs) vs active comparators
no estimate extracted6 studies · 388 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Anxiety, change from baseline
Mindfulness‐based interventions (MBIs) vs active comparators
no estimate extracted9 studies · 438 participantsModerate
Downgraded: risk of bias
Depression, change from baseline
Mindfulness‐based interventions (MBIs) vs active comparators
no estimate extracted11 studies · 595 participantsModerate
Downgraded: risk of bias
Perceived stress, change from baseline
Mindfulness‐based interventions (MBIs) vs active comparators
no estimate extracted6 studies · 357 participantsModerate
Downgraded: risk of bias, imprecision
Well‐being
Mindfulness‐based interventions (MBIs) vs active comparators
no estimate extracted1 study · 63 participantsLow
Downgraded: imprecision
Adverse events
Mindfulness‐based interventions (MBIs) vs active comparators
no estimate extractedNRNo studies
Smoking cessation
Mindfulness‐based interventions (MBIs) vs active comparators
RR 1.45 [0.78, 2.68]6 studies · 1087 participantsLow
Downgraded: risk of bias, inconsistency

Mindfulness‐based interventions (MBIs) compared to non‐active comparators for the primary and secondary prevention of cardiovascular disease

Population: people at high risk of or withcardiovascular disease
9 questions
OutcomeEffectEvidenceStatus / GRADE
Clinical CVD events (CVD mortality and non‐fatal MI)
Mindfulness‐based interventions (MBIs) vs non‐active comparators
RR 0.94 [0.37, 2.42]1 study · 110 participantsVery low
Downgraded: risk of bias, imprecision
Systolic blood pressure (mmHg), change from baseline
Mindfulness‐based interventions (MBIs) vs non‐active comparators
no estimate extracted9 studies · 379 participantsLow
Downgraded: risk of bias, inconsistency
Diastolic blood pressure (mmHg), change from baseline
Mindfulness‐based interventions (MBIs) vs non‐active comparators
no estimate extracted9 studies · 379 participantsLow
Downgraded: risk of bias, inconsistency
Anxiety, change from baseline
Mindfulness‐based interventions (MBIs) vs non‐active comparators
no estimate extracted9 studies · 533 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Depression, change from baseline
Mindfulness‐based interventions (MBIs) vs non‐active comparators
no estimate extracted15 studies · 912 participantsLow
Downgraded: risk of bias, inconsistency
Perceived stress, change from baseline
Mindfulness‐based interventions (MBIs) vs non‐active comparators
no estimate extracted11 studies · 708 participantsLow
Downgraded: risk of bias, inconsistency
Well‐being
Mindfulness‐based interventions (MBIs) vs non‐active comparators
no estimate extracted2 studies · 198 participantsModerate
Downgraded: imprecision
Adverse events
Mindfulness‐based interventions (MBIs) vs non‐active comparators
RR 5 [0.27, 91.52]1 study · 18 participantsLow
Downgraded: imprecision
Smoking cessation
Mindfulness‐based interventions (MBIs) vs non‐active comparators
RR 1.36 [0.86, 2.13]2 studies · 453 participantsLow
Downgraded: risk of bias, imprecision

Transcendental meditation (TM) compared to active comparators for the primary and secondary prevention of cardiovascular disease

Population: people at high risk of or with cardiovascular disease
9 questions
OutcomeEffectEvidenceStatus / GRADE
Clinical CVD events (CVD mortality, non‐fatal MI and stroke, revascularisations)
Transcendental meditation (TM) vs active comparators
RR 0.91 [0.56, 1.49]1 study · 201 participantsLow
Downgraded: imprecision
Systolic blood pressure (mmHg), change from baseline
Transcendental meditation (TM) vs active comparators
no estimate extracted8 studies · 774 participantsModerate
Downgraded: risk of bias, imprecision
Diastolic blood pressure (mmHg), change from baseline
Transcendental meditation (TM) vs active comparators
no estimate extracted8 studies · 774 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Anxiety, change from baseline
Transcendental meditation (TM) vs active comparators
no estimate extracted3 studies · 200 participantsLow
Downgraded: risk of bias, imprecision
Depression, change from baseline
Transcendental meditation (TM) vs active comparators
no estimate extracted5 studies · 421 participantsModerate
Downgraded: risk of bias, imprecision
Perceived stress, change from baseline
Transcendental meditation (TM) vs active comparators
no estimate extracted3 studies · 194 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Well‐being
Transcendental meditation (TM) vs active comparators
no estimate extractedNRNo studies
Adverse events
Transcendental meditation (TM) vs active comparators
no estimate extractedNRNo studies
Smoking cessation
Transcendental meditation (TM) vs active comparators
no estimate extractedNRNo studies

Transcendental meditation (TM) compared to non‐active comparators for the primary and secondary prevention of cardiovascular disease

Population: people at high risk of or withcardiovascular disease
9 questions
OutcomeEffectEvidenceStatus / GRADE
Clinical CVD events
Transcendental meditation (TM) vs non‐active comparators
no estimate extractedNRNo studies
Systolic blood pressure (mmHg), change from baseline
Transcendental meditation (TM) vs non‐active comparators
no estimate extracted2 studies · 139 participantsLow
Downgraded: risk of bias, imprecision
Diastolic blood pressure (mmHg), change from baseline
Transcendental meditation (TM) vs non‐active comparators
no estimate extracted2 studies · 139 participantsLow
Downgraded: risk of bias, imprecision
Anxiety, change from baseline
Transcendental meditation (TM) vs non‐active comparators
no estimate extracted1 study · 112 participantsLow
Downgraded: risk of bias, imprecision
Depression, change from baseline
Transcendental meditation (TM) vs non‐active comparators
no estimate extracted1 study · 112 participantsLow
Downgraded: risk of bias, imprecision
Perceived stress
Transcendental meditation (TM) vs non‐active comparators
no estimate extractedNRNo studies
Well‐being
Transcendental meditation (TM) vs non‐active comparators
no estimate extractedNRNo studies
Adverse events
Transcendental meditation (TM) vs non‐active comparators
no estimate extractedNRNo studies
Smoking cessation
Transcendental meditation (TM) vs non‐active comparators
no estimate extractedNRNo studies